CollPlant Biotechnologies (CLGN) Profit After Tax (2017 - 2026)
CollPlant Biotechnologies (CLGN) posted Profit After Tax of $3.1 million for Q1 2026, down 84.34% on a QoQ basis from $19.8 million in Q4 2025, and up 113.29% year-over-year from $1.5 million in Q1 2025.
CollPlant Biotechnologies (CLGN) Profit After Tax (2017 - 2026) Analysis & Trends
CollPlant Biotechnologies' Profit After Tax history runs 10 years deep, the most recent figure standing at $3.1 million for Q1 2026.
- Quarterly Profit After Tax rose 113.29% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.7 million (up 335.98% YoY) and the FY2025 annual result came in at $11.5 million, down 30.83% from the prior year.
- Profit After Tax was $3.1 million for Q1 2026 at CollPlant Biotechnologies, down from $19.8 million in the prior quarter.
- Across five years, Profit After Tax topped out at $19.8 million in Q4 2025 and bottomed at -$4.4 million in Q3 2022.
- A 5-year average of $3.5 million and a median of $3.9 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax sank 242.31% — and 2025, when it soared 409.82%.
- CollPlant Biotechnologies' Profit After Tax stood at $4.4 million in 2022, then rose by 6.54% to $4.7 million in 2023, then decreased by 17.3% to $3.9 million in 2024, then surged by 409.82% to $19.8 million in 2025, then tumbled by 84.34% to $3.1 million in 2026.
- Business Quant data shows CLGN's Profit After Tax at $3.1 million in Q1 2026, $19.8 million in Q4 2025, and -$3.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -453.82 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | 3.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | 3.10 Mn |
| Dec 31, 2025 | 19.77 Mn |
| Sep 30, 2025 | -3.48 Mn |
| Jun 30, 2025 | 3.35 Mn |
| Mar 30, 2025 | 1.45 Mn |
| Dec 31, 2024 | 3.88 Mn |
| Sep 30, 2024 | -4.33 Mn |
| Jun 30, 2024 | 4.21 Mn |
| Mar 31, 2024 | 4.20 Mn |
| Dec 31, 2023 | 4.69 Mn |
| Sep 30, 2023 | 4.38 Mn |
| Jun 30, 2023 | 5.76 Mn |
| Mar 31, 2023 | 3.72 Mn |
| Dec 31, 2022 | 4.40 Mn |
| Sep 30, 2022 | -4.38 Mn |
| Jun 30, 2022 | 4.29 Mn |
| Mar 31, 2022 | 3.86 Mn |
| Dec 31, 2021 | -3.77 Mn |
| Sep 30, 2021 | 3.08 Mn |
| Jun 30, 2021 | -3.04 Mn |